Get started
Author

Sören Dräger

ORCID: 0000-0002-3701-8365
Observed ORCID: 0000-0002-3701-8365
OpenAlex ID: A5014374667
T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita
2016 · Katja Bieber, Mareike Witte, et al. · Scientific Reports · 48
S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology
2024 · Frédéric Caux, Aikaterini Patsatsi, et al. · Journal of the European Academy of Dermatology and Venereology · 43
PDF
Increased TREM-1 expression in inflamed skin has no functional impact on the pathogenesis of cutaneous disorders
2017 · Sören Dräger, Kathrin Kalies, et al. · Journal of Dermatological Science · 9
Treating cellulitis promptly with compression therapy reduces C‐reactive protein‐levels and symptoms – a randomized‐controlled trial
2025 · Sören Dräger, Charlotte Kiehne, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 8
PDF
Pemphigoid disease model systems for clinical translation
2025 · Marvin Tigges, Sören Dräger, et al. · Frontiers in Immunology · 7
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
2021 · Katharina Boch, Sören Dräger, et al. · PLoS ONE · 6
PDF
Increased risk of deep vein thrombosis, pulmonary embolism, and all-cause mortality in chronic venous disorder: a large-scale retrospective cohort study
2025 · Eva Lotta Moderegger, Sören Dräger, et al. · Frontiers in Medicine · 3
PDF
Epidermolysis Bullosa Acquisita
2021 · Sören Dräger, Ralf J. Ludwig · Springer eBooks · 2
CD19×CD3 bispecific T cell engager treatment induces remission in experimental pemphigoid disease
2026 · Natalie Gross, Alexander Jochimsen, et al. · Molecular Therapy Advances · 1
Identifying common risk factors for primary cellulitis in a large-scale retrospective cohort study
2026 · Philip Curman, Sören Dräger, et al. · International Journal of Infectious Diseases · 1
PDF
ERK5 is required for neutrophil-mediated ROS release and a key contributor in epidermolysis bullosa acquisita
2025 · Sören Dräger, Mareile Schlotfeldt, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Epidermolysis bullosa acquisita
2023 · Sören Dräger · Haug Verlag in Georg Thieme Verlag KG eBooks · 1
Referenz Dermatologie
2023 · Ralf Ludwig, Wolf-Henning Boehncke, et al. · Haug Verlag in Georg Thieme Verlag KG eBooks · 1
Psychological stress documentation and subsequent risk of chronic inflammatory skin diseases: a large-scale real-world cohort study
2026 · Philip Curman, Emelie Fischer, et al. · Frontiers in Immunology
PDF
Localized Scleroderma Is Associated with an Increased Risk of Systemic Sclerosis: A Matched Cohort Study
2026 · Bastian Aschoff, Gabriela Riemekasten, et al. · Acta Dermato Venereologica
PDF
Die frühzeitige Behandlung des Erysipels mittels Kompressionstherapie reduziert das C‐reaktive Protein und Symptome – Ergebnisse einer randomisiert kontrollierten Studie
2025 · Sören Dräger, Charlotte Kiehne, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Sita‐ and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross‐sectional study
2025 · Sören Dräger, Claudia Kauderer, et al. · Journal of the European Academy of Dermatology and Venereology
PDF
Distinct Impact of Phosphodiesterade-4 (PDE4) Inhibition in Two Pre-clinical Psoriasis Models
2025 · Sören Dräger, Thorge Mester, et al. · Acta Dermato Venereologica
PDF
Mit intermittierender pneumatischer Kompression Amputationen abwenden – am Beispiel eines Ulcus hypertonicum (Martorell)
2022 · Lasse Kröger, Sören Dräger, et al. · Phlebologie
Works count: 19
Citation count: 131
H-index: 6
I10-index: 2
Year
Topic
Type